Literature DB >> 20363861

New insights into the not-so-new NR3 subunits of N-methyl-D-aspartate receptor: localization, structure, and function.

Chian-Ming Low1, Karen Siaw-Ling Wee.   

Abstract

The NR3 subunits (NR3A and NR3B) are new players in a well established field of N-methyl-d-aspartate (NMDA) receptors, previously involving the NR1 and NR2 subunits. Their incorporation into conventional NMDA receptors forms glutamate-activated NR1/NR2/NR3 triheteromers, whereas the omission of the glutamate-binding NR2 subunits results in excitatory glycine-activated NR1/NR3 diheteromers. These NR3-containing NMDA receptors exhibit several differences in receptor properties compared with the conventional NR1/NR2 receptors. This review highlights the major landmarks that have been achieved in the past decade or so involving NR3 subunit research in four key areas: the spatiotemporal mapping of NR3 protein, the structural elucidation of NR3 domains, pharmacological characterization of NR3-containing receptors, and the successful generation of NR3 knockout/transgenic animals. It is expected that further characterization of their functional roles coupled with the identification of endogenous and exogenous ligands will eventually advance the understanding of the basic pharmacology and the complex role of NMDA receptors in higher brain functions and neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363861     DOI: 10.1124/mol.110.064006

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  41 in total

1.  Strain differences in the effects of chronic corticosterone exposure in the hippocampus.

Authors:  G E Hodes; B R Brookshire; T E Hill-Smith; S L Teegarden; O Berton; I Lucki
Journal:  Neuroscience       Date:  2012-06-23       Impact factor: 3.590

Review 2.  Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

Authors:  Peter K Stys; Haitao You; Gerald W Zamponi
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

Review 3.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

Review 4.  Emerging roles of GluN3-containing NMDA receptors in the CNS.

Authors:  Isabel Pérez-Otaño; Rylan S Larsen; John F Wesseling
Journal:  Nat Rev Neurosci       Date:  2016-08-25       Impact factor: 34.870

5.  Presynaptic NMDA receptors also make the switch.

Authors:  Andrés Buonanno
Journal:  Nat Neurosci       Date:  2011-03       Impact factor: 24.884

6.  NMDA receptor signaling: death or survival?

Authors:  Tong Luo; Wei-Hua Wu; Bo-Shiun Chen
Journal:  Front Biol (Beijing)       Date:  2011-10-20

7.  NMDA receptor expression and C terminus structure in the rotifer Brachionus plicatilis and long-term potentiation across the Metazoa.

Authors:  Nathan J Kenny; Peter K Dearden
Journal:  Invert Neurosci       Date:  2013-04-02

8.  An increase in the association of GluN2B containing NMDA receptors with membrane scaffolding proteins was related to memory declines during aging.

Authors:  Daniel R Zamzow; Valerie Elias; Michelle Shumaker; Cameron Larson; Kathy R Magnusson
Journal:  J Neurosci       Date:  2013-07-24       Impact factor: 6.167

Review 9.  How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.

Authors:  Xin Wang; António Pinto-Duarte; Terrence J Sejnowski; M Margarita Behrens
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

10.  Moderate prenatal alcohol exposure reduces plasticity and alters NMDA receptor subunit composition in the dentate gyrus.

Authors:  Megan L Brady; Marvin R Diaz; Anthony Iuso; Julie C Everett; C Fernando Valenzuela; Kevin K Caldwell
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.